Get started
000

NEOVACS EUR1 (POST CONSOLIDATION)

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

0W8U chart


Full chart

Key stats


Market capitalization
‪297.38 K‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−160,192.500 EUR
Net income (FY)
‪−8.74 M‬ EUR
Revenue (FY)
‪533.41 K‬ EUR
Shares float
—
Beta (1Y)
2.58

About NEOVACS


Sector
Health Technology
CEO
Hugo Brugière
Headquarters
Suresnes
Website
neovacs.fr
Founded
1992
ISIN
FR001400TG47
FIGI
BBG00JVXHR30
Neovacs SA is a biotechnology company focused on therapeutic vaccines targeting the treatment of autoimmune diseases. The firm is developing a product portfolio using its Kinoid technology through self-antigens, which cause autoimmune or inflammatory diseases. Its product portfolio includes IFNa kinoid, IL-4/13 kinoid, and IgE kinoid. The company was founded by Daniel Zagury on April 16, 1993 and is headquartered in Paris, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0W8U news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0W8U is 20,000.000 EUR — it has decreased by −92.86% in the past 24 hours. Watch NEOVACS EUR1 (POST CONSOLIDATION) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange NEOVACS EUR1 (POST CONSOLIDATION) stocks are traded under the ticker 0W8U.
0W8U reached its all-time high on Jan 30, 2018 with the price of 4,392,000,316,855,899.000 EUR, and its all-time low was 20,000.000 EUR and was reached on Feb 6, 2024. View more price dynamics on 0W8U chart.
See other stocks reaching their highest and lowest prices.
0W8U stock is ‪1.30 K‬% volatile and has beta coefficient of 2.58. Track NEOVACS EUR1 (POST CONSOLIDATION) stock price on the chart and check out the list of the most volatile stocks — is NEOVACS EUR1 (POST CONSOLIDATION) there?
Today NEOVACS EUR1 (POST CONSOLIDATION) has the market capitalization of ‪297.38 K‬, it has decreased by −1.00% over the last week.
Yes, you can track NEOVACS EUR1 (POST CONSOLIDATION) financials in yearly and quarterly reports right on TradingView.
0W8U net income for the last half-year is ‪−30.99 M‬ EUR, while the previous report showed ‪−4.46 M‬ EUR of net income which accounts for −594.80% change. Track more NEOVACS EUR1 (POST CONSOLIDATION) financial stats to get the full picture.
No, 0W8U doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEOVACS EUR1 (POST CONSOLIDATION) EBITDA is ‪−6.75 M‬ EUR, and current EBITDA margin is ‪−1.26 K‬%. See more stats in NEOVACS EUR1 (POST CONSOLIDATION) financial statements.
Like other stocks, 0W8U shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEOVACS EUR1 (POST CONSOLIDATION) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEOVACS EUR1 (POST CONSOLIDATION) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEOVACS EUR1 (POST CONSOLIDATION) stock shows the strong sell signal. See more of NEOVACS EUR1 (POST CONSOLIDATION) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.